secwatch.observer — SEC 8-K summary
======================================

Issuer:     Century Therapeutics, Inc. (IPSC)
CIK:        0001850119
Form:       8-K
Filed at:   2026-06-12T20:06:04+00:00
Accession:  0001104659-26-073429
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Century Therapeutics shareholders approve increase in authorized common stock to 450M shares
--------------------------------------------------------------------------------

- Stockholders approved amendment to increase authorized common stock from 300M to 450M shares; effective June 12, 2026.
- Alessandro Riva, M.D. and Han Lee, Ph.D., M.B.A. elected as Class II directors until 2029 annual meeting.
- Ratification of Ernst & Young LLP as independent auditor for fiscal 2026 received 135.6M votes for, 107K against.
- Proposal to adjourn meeting passed but was unnecessary after share amendment approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850119/000110465926073429/0001104659-26-073429-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850119/000110465926073429/tm2617728d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-073429

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer